PATENT CLAIM ANALYSIS

Application Number: 15869431
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["435", "006100"]

Abstract:
The present invention relates to methods that are useful for predicting the response of hepatitis B virus (HBV) infected patients to pharmacological treatment.

Claim (Index 3):
A method for determining the likelihood that a patient with an HBV infection will exhibit benefit from an anti-HBV treatment comprising an interferon, the method comprising:\n determining the presence of a single nucleotide polymorphism in gene FCER1A on chromosome 1 in a sample obtained from the patient, wherein the presence of at least one A allele at rs7549785 indicates that the patient has increased likelihood of benefit from the anti-HBV treatment.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.04
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14373611', '11375580', '10618620', '11375585', '13774960']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.553383872120822
- 35 USC 102 Novelty (BERT): 0.5008454897261044
- Combined Prediction Score: 0.5481300338813502
- Mean Citation Score: 238.37690000000003
- Max Citation Score: 266.92334
- Similarity Product: 216.1059396740341

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test